Relay Therapeutics, Inc.
RLAY
$12.78
-$0.44-3.33%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/15/2026
-
Tickeron - Stocks
5/15/2026
-
Tickeron - Stocks
5/12/2026
-
Insider Monkey
5/11/2026
-
Simply Wall St
5/11/2026
-
Finbold Stock News
5/10/2026
-
Insider Monkey
5/9/2026
-
MarketBeat
5/7/2026
-
Simply Wall St
5/6/2026
-
MarketBeat
5/6/2026
-
TipRanks Financial Blog
5/5/2026
-
TipRanks Financial Blog
5/5/2026
-
MarketBeat
5/5/2026
-
Zacks Investment Research
5/5/2026
-
Zacks Investment Research
5/5/2026
-
Globe Newswire
5/4/2026
-
24/7 Wall St.
5/4/2026
-
Simply Wall St
5/2/2026
-
Simply Wall St
5/2/2026
-
The Cerbat Gem
5/1/2026
-
MarketBeat
5/1/2026
-
MarketBeat
4/30/2026
-
MarketBeat
4/30/2026
-
MarketBeat
4/30/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 5, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 370 8837
Address
60 Hampshire Street
Cambridge, MA 02139
Cambridge, MA 02139
Country
Year Founded
Business Description
Sector
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in...
more